Keywords: biologics, worth, 2b, lose, patents, branded, biological
Biologics worth $11.2B to lose patents by 2010
Article | 09 May 2005
Branded biological drugs generated an estimated total of $32.0 billion in sales for the biotechnology and pharmaceutical industries in 2003 and represented ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
